Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine and IBZM SPECT in Alcohol Dependence
NCT00437177Phase 2Unknown
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jan 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apomorphine, iodobenzamide I-123 in alcohol dependence, sponsored by Vall d'Hebron Research Institute. Status: unknown.
02
Drugs
apomorphineiodobenzamide I-123
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00437177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437177.